Xiamen Amoytop Biotech Co (SHSE:688278) Marketable Securities: ¥111 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688278 Xiamen Amoytop Biotech Co Ltd SHSE:688278
75 GF Score
Price ¥57.00
GF Value ¥106.96
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Xiamen Amoytop Biotech Co Marketable Securities?

Xiamen Amoytop Biotech Co SHSE:688278 +0.07% 75 Marketable Securities is ¥111 Mil as of Jun. 2026. GuruFocus rates SHSE:688278 with a GF Score™ of 75/100 and a GF Value™ of ¥106.96 (Possible Value Trap). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Xiamen Amoytop Biotech Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥111 Mil.

Xiamen Amoytop Biotech Co's annual Marketable Securities increased from Dec. 2023 (¥257 Mil) to Dec. 2024 (¥290 Mil) and increased from Dec. 2024 (¥290 Mil) to Dec. 2025 (¥462 Mil).

Xiamen Amoytop Biotech Co  (SHSE:688278) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Xiamen Amoytop Biotech Co Marketable Securities Related Terms

Xiamen Amoytop Biotech Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Xiamen Amoytop Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xiamen Amoytop Biotech Co Marketable Securities Chart

Xiamen Amoytop Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 196.38 270.78 257.08 289.96 462.48

Xiamen Amoytop Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.59 376.07 462.48 150.00 110.51
SHSE:688278
75GF Score
Xiamen Amoytop Biotech Co Ltd SHSE:688278
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xiamen Amoytop Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥111 Mil mean?
Xiamen Amoytop Biotech Co (SHSE:688278) has a Marketable Securities of ¥111 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Xiamen Amoytop Biotech Co and its competitors.
Is Xiamen Amoytop Biotech Co's Marketable Securities too high?
Xiamen Amoytop Biotech Co's current Marketable Securities is ¥111 Mil. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's Marketable Securities compare to VRTX and REGN?
Xiamen Amoytop Biotech Co's Marketable Securities of ¥111 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Xiamen Amoytop Biotech Co and its competitors. Xiamen Amoytop Biotech Co's current Marketable Securities is ¥111 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥106.96, compared to a current price of ¥57.00 — trading 46.7% below its estimated fair value. The current Marketable Securities is ¥111 Mil. Xiamen Amoytop Biotech Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current Marketable Securities is ¥111 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?

Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued. The current stock price of ¥57.00 is trading 46.7% below its estimated GF Value™ of ¥106.96. GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.

Key valuation signals for SHSE:688278:

  • Marketable Securities: ¥111 Mil
  • GF Value™: ¥106.96 vs. price of ¥57.00 (46.7% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xiamen Amoytop Biotech Co Business Description

Address No.330 Wengjiao Road, Xinyang Industry Zone of Haicang, Fujian, Xiamen, CHN, 361022
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
75GF Score

Get the complete analysis for SHSE:688278

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥57.00
Price
¥106.96
GF Value